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The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates IAN SUTHERLAND' AND V H SPRINGETT2 From the 'MRC Biostatistics Unit, Cambridge; and 2Birmingham.
ABSTRACr The aims ofthis paper were to estimate the numbers oftuberculosis notifications in young white adults which will be prevented in the next 25 years by the schools BCG vaccination scheme, and to assess the numbers ofadditional notifications ifthe scheme were to be discontinued. Assuming that in the white ethnic group in England and Wales the decline in tuberculosis notification rates (8-10% per year for ages less than 45 years) and efficacy of BCG vaccination (75-80%) are maintained,;it is estimated that the scheme for BCG vaccination of schoolchildren with its present coverage will prevent 217 notifications in those aged 15-29 years in 1993, 119 in 1998, and 69 in 2003. The epidemiological consequences of stopping the BCG in schools scheme, whenever this occurs, would be a substantial slowing of the rate ofdecline oftuberculosis notifications, confined almost entirely to the 15-29 years age group, for a period of about 15 years, after which the steeper decline would resume. Ifthe scheme stopped at the end of 1991 the annual number ofadditional notifications would slowly increase to a maximum ofjust over 80 about 15 years later, and then decrease. For stopping at the end of 1996 the maximum annual number of additional notifications would be about 50.
The Medical Research Council (MRC) trial of tuberculosis vaccines, which began in 1950, showed that BCG vaccine, given at age 14 years in England and Wales, was highly effective in preventing tuberculosis for a period of at least 15 years.' 2 A national scheme for BCG vaccination in schools at about age 13 years was introduced in 1953. The scheme developed slowly, but by 1962 about 60 per cent ofeach cohort aged 13 years received the vaccine. This percentage rose to about 70 per cent by 1970, and has remained at about 75 per cent since 1977.3 The preventive benefits of this scheme have undoubtedly been considerable, though they have never been formally evaluated. However, soon after the scheme was introduced the first evidence appeared of the much steeper decreases in tuberculous infection and tuberculosis incidence which have taken place since about 1950. 4 The absolute benefit from the scheme, in terms of the numbers of cases of tuberculosis prevented, will have risen during the first 10-15 years as the vaccination of successive annual cohorts aged 13 years gradually extended protection throughout the 15-29 year age group. But since then, the absolute benefit to this age group will have decreased steeply, in parallel with the declining incidence of the disease.
In a succession ofmonitoring studies, the efficacy of BCG vaccine in routine use in Britain has been examined in relation to technical changes in the vaccine56 and the decreasing risk of exposure to the disease.79 In another series ofstudies, the incidence of tuberculosis has been examined according to place of birth'1'2 and ethnic group,'3 and the secular trends in tuberculosis incidence in the white and other ethnic communities in England and Wales have also been investigated.'"'6 The information from the two most recent of these studies9 16 allows the present position to be assessed, and forward projections to be made, with reasonable confidence.
The aims of the present paper are as follows: (1) to estimate the numbers of notifications of tuberculosis in young white adults aged 15-29 years that are now prevented, and will be prevented annually during the next 25 years in England and Wales, assuming the continuation of the BCG in schools scheme at its present level; (2) to assess the numbers of additional notifications that would be expected among young white adults each year, if the scheme were to be discontinued at certain specified dates.
The present and future usefulness of the scheme as a tuberculosis control measure in schoolchildren in England and Wales, taking into account the financial 16 implications of the scheme as well as the availability and efficacy of other methods of controlling the disease, will be considered in the light of these estimates in a separate report (in preparation).
These estimates are intentionally being made in relation to the white population only. The scheme for BCG vaccination at about age 13 years, when it was introduced in 1953, was an appropriate method for the control of tuberculosis in the population of England and Wales, which was then almost entirely white; it is the present and future usefulness of this scheme, as a mass vaccination programme for the white population, which is under consideration. The scheme has undoubtedly also been of benefit in recent years The final column of table 3 presents the same information in inverse form, namely as the number of vaccinations required to prevent one notification during the 15 year period. From a figure of 67 vaccinations in the MRC vaccines trial, the estimate for 1984 was 2200; by 1989 it is estimated that it will require 3600 and by 1994, 5800 BCG vaccinations of white schoolchildren to prevent one tuberculosis notification during the 15 year period.
Total numbers ofnotificationsprevented in Englandand
Wales Table 4 gives estimates of the total numbers of tuberculosis notifications prevented throughout 1-07 thus provides an estimate of the increased risk to an unvaccinated individual in 1993 (that is, when the first wholly unvaccinated five year cohort was aged 15-19 years), above the level which would have applied if the scheme had continued. The corresponding ratios when the cohort was aged 20-24 and 25-29 years would have been 1-3 and 1.5 respectively. The same ratios would apply following each future date of stopping. On this basis, if the scheme had stopped at the end of 1986, the estimated risk to a white adult of developing tuberculosis between ages 15 and 30 years for the first wholly unvaccinated five year cohort, that is, for those aged 13 years in 1987-91 (central year 1989), would have been 1 in 2200 compared with 1 in 2700 if vaccination had continued (table 2) .
Moreover, the figure of 1 in 2200 may be regarded as an overestimate because it assumes that all the secondary additional notifications would have been in the age group 15-29 years. For the later wholly unvaccinated cohorts, the risks would have been less than for the first 5 year cohort, because the total notification rate at ages 15-29 years would have continued to decrease after the scheme had stopped.
If the scheme were to be discontinued at the end of 1991, an unvaccinated tuberculin negative white individual aged 13 years in 1992-96 would face a maximum risk of developing tuberculosis between ages 15 and 30 years of 1 in 3400, compared with 1 in 4300 if the scheme had continued. The corresponding figure for an individual aged 13 years in 1997-2001, the scheme having stopped at the end of 1996, would be 1 in 5400, compared with 1 in 6900 ifthe scheme had continued. Secondary consequences-The primary additional notifications would all be in the age group 15-29 years, and would all arise from the existing sources of infection in the community. They would also represent new sources of infection, which would be expected to give rise to further tuberculosis notifications or chains of notifications according to the same pattern as the existing sources are expected to do. These generations of notifications, all linked to an initial infection from one of the primary additional notifications, represent the secondary effects of stopping. These secondary additional notifications could be in individuals of any age, and would influence the decline in notification rate over a longer calendar period than the primary additional notifications.
The estimation of the numbers of secondary additional notifications, and their timing, is not as straightforward as for the primary effects. The continuing decrease, in all age groups, in notification rates from the existing sources ofinfection implies that the total number of secondary additional notifications from the new sources, over the entire age range, must be less than the number of primary additional notifications in young adults which gave rise to them. Estimates of the total number and its time scale, however, depend additionally on knowing the average time interval between each notification and the notification of the individual who infected him or her, as explained in appendix 2. Although evidence on the duration of this average interval is limited, there is good reason to believe that it is not less than 2 years (see appendix 2), and this figure has been used for the estimates in table 5. If the average interval between linked notifications is greater than this, the total number of secondary notifications would be smaller and spread over a longer period of time. The figures in table 5 may thus be regarded as maximum estimates of the size and rapidity of the secondary effects of stopping.
Effect on the downward trend in notification rateThe primary additional notifications would influence the decline in notification rate in young adults only until the entire 15-29 year age group had become unvaccinated, and the major effects of the secondary additional notifications derived from them would occur over the same period. There would thus be only a temporary disturbance to The total consequences of stopping the BCG scheme, at any future date, would thus seem to be reliably estimated and summarised as a temporary slowing of the decline in the notification rate in young white adults from a figure of 9 per cent annually to about 3 per cent annually, for a period of about 15 years. Thereafter a steeper rate of decline would be expected to resume in this age group.
This detailed analysis has shown that if the BCG in schools scheme were to be stopped, the consequences would be limited in time and would not be epidemiologically disastrous. It is important to appreciate that this is so because tuberculosis in England and Wales is essentially an endemic disease which is decreasing steeply for reasons unconnected with the efficacy of BCG or its application in the schools scheme. The additional notifications expected after stopping, both primary and secondary, would lead to only a temporary disturbance in the basic epidemiological trend which preceded the introduction of the scheme, and has continued during it (table 1), namely a steeply decreasing tuberculosis incidence in unvaccinated young adults. The situation is quite different from that ofan infectious disease with a different basic epidemiology. The effect of abandoning (or of a substantial reduction in) measles vaccination in this country, for example, could be analysed, and the numbers ofprimary additional cases estimated, in the same way as for tuberculosis. But for measles, the secondary additional cases would not be a decreasing series, and the disease would be expected to revert rapidly to the basic epidemiological pattern It has been assumed throughout this paper that the preventive efficacy of BCG lasts for 15 years, and (tacitly) for no longer. If this is so, the benefits of continuing the scheme will be confined to the age group 15-29 years. The effects of stopping it will also be confined to this age group, except for the occurrence of a diminishing number of secondary additional notifications outside this age group and after more than 15 years. It is however more likely that some protection from BCG will continue in England and Wales for more than 15 years after vaccination, and that the benefits ofvaccination in the scheme have also extended to those who are now aged more than 30 years. In these circumstances, primary and secondary effects of stopping the scheme will also occur at ages above 30 years. The size of these effects will be small, because they will not begin to occur until the first wholly unvaccinated cohort reaches the age of 30 years, that is, more than 15 years after the scheme is discontinued. Consequently they have not been explored further in this paper.
TUBERCULOSIS AND ACQUIRED IMMUNO-DEFICIENCY SYNDROME (AIDS)
Patients with AIDS following human immunodeficiency virus (HIV) infection have an increased susceptibility to tuberculosis.17 There is understandable concern that the expected increase in the number of AIDS patients in England and Wales will also lead to increased numbers of tuberculosis notifications, and that this may seriously disturb the current downward trend of the disease. In particular, the forward projections in this paper might be affected.
The effects on the incidence of tuberculosis of an increase in the proportion of the population with AIDS are epidemiologically analogous to the consequences of an increase in the proportion of the population left unvaccinated after stopping the BCG scheme. The primary effect would be additional cases of tuberculosis among those whose susceptibility to the disease had been increased by AIDS. These cases would arise partly from the breakdown of quiescent tuberculosis infections which had preceded the development of AIDS (endogenous reactivation) and partly from fresh tuberculous infections following the development of AIDS (exogenous infection). These primary additional cases would represent potential new sources of infection in the community, and the further cases of tuberculosis to which they gave rise would represent the secondary effect.
The numbers of primary additional cases would depend on the proportion of the population that develops AIDS, the proportion of these who have had 22 a past, or experience a fresh, tuberculous infection, and the (at present unknown) extent to which susceptibility either to breakdown of quiescent tuberculous infection or to fresh tuberculous infection is increased by AIDS. The increases with time in the proportion of the population with AIDS will be offset to some extent by the expected continuation of the substantial annual decreases in the proportion of the population infected with tuberculosis. The number of primary additional cases of tuberculosis will therefore not rise as rapidly as the proportion of the population with AIDS, and the totals will not necessarily become large.
The current steep downward trend in the incidence of tuberculosis in the general population not suffering from AIDS reflects a similar downward trend in the number of sources oftuberculous infection. This trend will be disturbed by an increase in primary additional cases of tuberculosis with AIDS, to the extent that these additional cases represent new sources of infection for the general population. It should be possible for the infectivity of cases of tuberculosis in patients with AIDS to be controlled with chemotherapy, and their life expectancy and therefore duration of infectivity is also limited by their susceptibility to other infections. It is not at present possible to assess the combined effects of all these factors on the risk of tuberculosis infection in the community. There could be circumstances in which the downward trend in the risk of tuberculous infection (and hence the projections in this paper) would be seriously disturbed, but this is by no means an inevitable outcome. with the number actually recorded in the 1988 survey will indicate whether our future estimates of the notifications prevented by the scheme, if it continues, and ofthe additional notifications if it is discontinued, should both be regarded as too large or both as too Ian Sutherland and V H Springett small. However, the new information will not radically alter the pattern of the effects of continuing the scheme, nor the pattern of the consequences of stopping the scheme, that have been presented above, unless the survey reveals large departures from the expected trends in several age groups.
As indicated in the introduction, the present and future usefulness of the BCG in schools scheme as a tuberculosis control measure, in the light of these estimates, will be considered in a separate report (in preparation). (1) Let the average interval between the notification of any individual and the notification of the patient who infected that individual be z years. Ifthe notification rate is decreasing by a proportion d (> 0) each year, the expected total number of secondary notifications (T) arising eventually from any one primary notification is given by:
T=(1-d)z< 1 (2) Suppose that on average one notified patient infects y individuals, of whom x develop notified tuberculosis after an average interval of z years. These x notifications will be expected to lead to a second generation of x2 notifications on average z years later, these to a third generation of x3 notifications z years later, and so on. The total number of secondary notifications expected to arise from one primary notification is thus:
T=x+x2+x3+.... and because x < T < 1, the sum of this series is T = x/(l -x) ( 3) The expected average interval (Z) between each primary notification and all the secondary notifications arising from it is given by:
x.z + x2.2z + x3.3z + ... It should be noted that if the true value of z is greater than 2 years, T and x will be smaller, and Z will be greater. The above figures may thus be regarded as maximum estimates of the size and rapidity of the secondary effects.
(6) The expected numbers of secondary additional notifications have been estimated as 82-8% of the primary additional notifications 3-7 years previously, and are shown in the third section of table 5.
